ArticleTherapeutic advances in gastroenterology2020
Trend of changes in antibiotic resistance in
Article in Therapeutic advances in gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The prevalence of clarithromycin-resistantPeerJ · 2023Pooled it
- A single-center culture-based study ofFrontiers in microbiology · 2026Article
- Resistance reversal: Taiwan'sWorld journal of gastroenterology · 2025Article
- Research progress of potassium-competitive acid blockers in the treatment ofAnnals of medicine · 2025Review
- Sequential changes of antibiotic resistances ofWorld journal of gastroenterology · 2025Article
- Characteristics of Successful Third-Line Eradication of Helicobacter pylori based on Antibiotic Susceptibility.Asian Pacific journal of cancer prevention : APJCP · 2025Observational
- Efficacy and safety of Qingwei Zhitong pellets-containing quadruple therapy for eradication: a prospective, single-center, randomized trial.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025Article
- Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan forMicroorganisms · 2025Review
- Emergence of amoxicillin resistance in refractoryTherapeutic advances in gastroenterology · 2025Article
- Comparative efficacy and safety of vonoprazan versus esomeprazole-based high-dose dual therapies for first-lineTherapeutic advances in gastroenterology · 2025Article
- 10-Day versus 14-day bismuth quadruple therapy for first-line eradication ofEClinicalMedicine · 2024Article
- Intraluminal Therapy forBiomedicines · 2023Article
- Evolution ofAntibiotics (Basel, Switzerland) · 2023Review
- Antibiotic Resistance ofJournal of clinical medicine · 2023Article
- Rescue therapy for refractoryTherapeutic advances in gastroenterology · 2023Review
- Update on the second-line treatment ofTherapeutic advances in gastroenterology · 2023Review
- Antibiotic resistance patterns of Helicobacter pylori in North Israel - A six-year study.Helicobacter · 2022Article
- Factors Affecting the Intraluminal Therapy forMicroorganisms · 2022Article
- Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Infection and drug resistance · 2021Article
- Culture-based antibiotic susceptibility testing forAnnals of gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntibiotic resistance plays a crucial role in the treatment failure of
methodsWe retrospectively analysed
resultsA progressively higher primary resistance rate was observed for clarithromycin (11.8-20.4%,
conclusionPrimary, secondary and tertiary antibiotic resistance to clarithromycin, levofloxacin and metronidazole for
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.